澳洋健康(002172) - 2015年7月28日投资者关系活动记录表
AYJKAYJK(SZ:002172)2022-12-08 02:26

Group 1: Viscose Staple Fiber Business - The market consensus is optimistic about the rising price trend of viscose, and the company is confident in the development of its viscose staple fiber business [2] - The Xinjiang production base is accelerating environmental investments and acceptance, aiming for early resumption of production while phasing out outdated capacity and expanding downstream appropriately [2] Group 2: Health Industry Development - In the medical service sector, the company has established a healthcare system centered around Aoyang Hospital, with branches like Yangshe, Sanxing, and Shunkang, focusing on basic medical care and specialty services [3] - Aoyang Pharmaceutical has become one of the largest private pharmaceutical logistics companies in East China, with a modern distribution network covering the region and extending nationwide [3] - The company aims to leverage its public platform for both internal development and external expansion in the health industry, striving to strengthen its position in this emerging main business [3]